baber/WOPTO huggingface dataset:
Patent AU-PR224600-A0 (AU)
Title: Novel polymers
IPC: B29C59/00
Filed: 2000-12-21
Abstract: The present invention relates generally to a grafting process comprising the formation of a grafted polymeric structure having a substrate polymer in hybrid formation with one or more of the same or other polymers or monomeric subunits thereof. More particularly, the present invention contemplates a method of generating a homogenous or heterogenous grafted polymer by inducing or otherwise facilitating free radical formation to initiate polymerization of monomer units corresponding to the same or different polymers to a substrate polymer previously subjected to physical stress means. The resulting hybrid polymer may comprise a substrate polymer and a population of a second or further polymers in homogenous or heterogenous hybrid formation with the substrate polymer. A homogenous population includes a grafted population of the same polymer whereas a heterogenous population comprises a grafted population of two or more different polymers. The homogenous or heterogenous population may be in a random or patterned array and may be regarded, in one embodiment, as reactive or interactive centres for solid phase organic synthesis and binding of polymeric and/or chemically interactive molecules. The present invention also discloses a method to render polymers, previously regarded as not being suitable material for graft formation, capable of receiving a graft polymer in a heterogenous or homogenous fashion. Thus, the instant invention permits the production of a new range of hybrid polymer including copolymer materials and blends of polymers.
Patent FI-20045137-A0 (FI)
Inventor: SAIKKONEN ARI
IPC: F02D19/10
Filed: 2004-04-16
Abstract: A method of operating a gas engine, the gas engine comprising a first fuel feed system (2), a second fuel feed system (3) and a third fuel feed system (4), in which method in the first operation mode the engine is run by introducing gaseous fuel into the engine (1) combustion air via the first fuel feed system (2), and the gaseous fuel is ignited by injecting ignition fuel into the mixture of gaseous fuel and combustion air via the second fuel feed system (3). In the second operation mode of the method the engine is run by still introducing gaseous fuel into the engine (1) combustion air via the first fuel feed system (2) and the gaseous fuel is ignited by injecting ignition fuel into the mixture of gaseous fuel and the combustion air via the third fuel feed system (3).
Patent IL-102105-A0 (IL)
Title: Amidino compounds,their manufacture and methods of treatment
IPC: A61K31/16
Filed: 1992-06-04
Abstract: The invention relates to the compounds of the formula <CHEM>  and pharmaceutically acceptable salts thereof, in which: R1 is amino which is mono- or disubstituted by a substituent selected from an aliphatic hydrocarbon radical, an araliphatic hydrocarbon radical, an aromatic radical, and a cycloaliphatic hydrocarbon radical or is amino which is disubstituted by a divalent aliphatic hydrocarbon radical; R2 is hydrogen, halogen, trifluoromethyl, an aliphatic hydrocarbon radical, or is hydroxy which is etherified by an aliphatic alcohol, araliphatic alcohol, or aromatic alcohol or which is esterified by an aliphatic or araliphatic carboxylic acid; R3 is hydrogen or an acyl radical which is derived from an organic carbonic acid, un organic carboxylic acid, a sulfonic acid, or a carbamic acid; X1 and X3, independently of one another, are oxygen (-O-) or sulphur (-S-); and X2 is a divalent aliphatic hydrocarbon radical which may be interrupted by an aromatic radical; wherein the phenyl rings of formula I may be, independently of one another, further substituted by one or more substituents selected from halogen, trifluoromethyl, un aliphatic hydrocarbon radical, hydroxy, and hydroxy which is etherified by an aliphatic alcohol or which is esterified by an aliphatic or araliphatic carboxylic acid; wherein aryl in the above definitions may be, independently of one another, further substituted by one or more substituents selected from halogen, trifluoromethyl, un aliphatic hydrocarbon radical, hydroxy, and hydroxy which is etherified by an aliphatic alcohol or which is esterified by an aliphatic or araliphatic carboxylic acid; wherein a cycloaliphatic hydrocarbon radical may be substituted by an aliphatic radical. The compounds are useful as selective LTB-4 receptor antagonists in the treatment of conditions or syndromes in mammals which are responsive to LTB-4 receptor antagonism.
Patent IL-104382-A0 (IL)
Title: Vaccine containing acemannan as an adjuvant
IPC: A61K39/245
Filed: 1993-01-13
Abstract: This invention provides a Herpesvirus of Turkeys vaccine which comprises per dose an effective immunizing amount of a modified live Herpesvirus of Turkeys, an amount of an acemannan effective to enhance the immunogenicity of the Herpesvirus of Turkeys and a suitable carrier. This invention also provides a vaccine which comprises per dose an effective immunizing amount of a modified live virus, an amount of an acemannan effective to enhance the immunogenicity of the modified live virus and a suitable carrier. This invention further provides a vaccine which comprises per dose an effective immunizing amount of a modified live virus, an amount of a complex carbohydrate effective to enhance the immunogenicity of the modified live virus and a suitable carrier. Still further provided are a method of immunizing a chick against Marek's Disease and methods of immunizing an animal against viral disease. This invention provides a bacterin which comprises per dose an effective immunizing amount of a bacterial antigen, an amount of an acemannan effective to enhance the immunogenicity of the bacterial antigen and a suitable carrier. This invention also provides methods of immunizing an animal against bacterial disease.
Patent IL-108071-A0 (IL)
Title: Substituted 4-phenyl-pyridones and 4-phenyl-2-alkoxypyridines their preparation and pharmaceutical compositions containing them
IPC: A61K31/443
Filed: 1993-12-17
Abstract: Substituted 4-phenylpyridones and 4-phenyl-2-alkoxypyridines are prepared by reducing corresponding 4-phenylpyridone derivatives and 4-phenyl-2-alkoxypyridine derivatives, respectively. The substituted 4-phenylpyridones and 4-phenyl-2-alkoxypyridines may be employed as active compounds in drugs (medicaments, pharmaceuticals, medicines), in particular for the treatment of hyperlipoproteinaemia.
Patent IL-111446-A0 (IL)
Title: Composite materials using bone bioactive glass and ceramic fibers
IPC: D03D1/00
Filed: 1994-10-28
Abstract: Composite materials formed from bone bioactive glass or ceramic fibers and structural fibers are disclosed. In preferred embodiments, a braid or mesh of interwoven bone bioactive glass or ceramic fibers and structural fibers is impregnated with a polymeric material to provide a composite of suitable biocompatibility and structural integrity. Most preferably, the mesh or braid is designed so that the bioactive fibers are concentrated at the surface of the implant to create a surface comprised of at least 30% bioactive material, thereby providing enhanced bone ingrowth. The interweaving between the bone bioactive glass or ceramic fibers and the core of structural fibers overcomes the problems found in prior composite systems where the bioactive material delaminates from the polymer. Preferred bioactive materials include calcium phosphate ceramics and preferred structural fibers include carbon fibers. Improved prosthetic implants and methods of affixing an implant are thus also disclosed.
Patent IL-126587-A0 (IL)
Title: Method and system for the prevention of undesirable activities of executable objects
IPC: H04L29/06
Filed: 1998-10-15
Abstract: A method of preventing undesirable activities of Executable Objects via an application, comprising denying to the same application, or one or more of its threads, access to a secured resource if the application, or one or more of its threads, has previously exhibited Internet behavior and has not met a specific condition for accessing the secured resource, and denying the application, or one or more of its threads, Internet behavior if, at a time access is sought to the Internet, the application, or one or more of its threads is accessing a secured resource.
Patent IL-131101-A0 (IL)
Title: Novel agaricus bisporus hybrids method for producing them and application
IPC: A01H15/00
Filed: 1998-01-27
Abstract: The invention concerns intraspecific hybrids of Agaricus bisporus capable of bearing fruit at relatively high temperature and without roughing-in, and the method for obtaining them consisting in a step of cross-breeding in particular between a first and a second Agaricus bisporus, one of which at least belongs to the burnettii variety, and a step of selecting the resulting hybrids having the characteristics mentioned above. The cultivation of the resulting hybrids is easier and less expensive than the standard method of cultivating mushrooms.
Patent IL-131328-A0 (IL)
Title: Self-regulated apoptosis of inflammatory cells by gene therapy
IPC: C12N15/09
Filed: 1998-02-27
Abstract: This invention relates to the therapeutic induction of apoptosis in activated inflammatory cells, or cells at a site of inflammation, by introducing into those cells a chimeric gene containing an apoptosis-inducing gene (AIG) driven by a promoter of an inducible gene activated in inflammation and a promoter enhancer such that the inflammatory cells are targeted. In one embodiment, the chimeric gene comprises at least one TNFalpha promoter enhancer attached to a functional copy of a minimal TNFalpha promoter and further attached to at least one copy of an apoptosis-inducing gene, wherein expression of the gene is driven by the TNFalpha promoter. Attachment can be direct, distal, proximal or combinations thereof. Example apoptosis-inducing genes include caspase 3, caspase 4, caspase 5, Granzyme B. Advantageously, the TNFp-AIG chimeric gene is expressed in only those cells producing the inflammatory cytokine, TNFalpha. In addition, the TNFp-AIG chimeric gene also sequesters inducible TNFp transcription factors, thereby reducing endogenous production of TNFalpha. The invention also relates to methods of making and using self-regulated apoptosis chimeric genes and pharmaceutical compositions containing them for treating inflammatory diseases.
Patent IL-140771-A0 (IL)
Title: Coating and excipient agent for oral or dermal dosage forms
IPC: C08L33/14
Filed: 1999-07-02
Abstract: The invention relates to a method for the production of a coating and excipient agent for oral or dermal dosage forms, consisting of (a) 35-98% by weight of a copolymer consisting of radically polymerized C1-C4 esters of acrylic or methacrylic acid and additional (meth)acrylate monomers having functional tertiary amino groups and (b) 1-50% by weight of a softener and 1-15% by weight of an emulgator with an HLB value of less than 14, wherein constituents (a), (b) and (c) are mixed with or without adding water and optionally adding a pharmaceutical active substance and other conventional additives and the coating and excipient agent is produced by melting, casing, spreading or spraying. The invention is characterized in that the copolymer (a) is applied in powder form with a mean particle size of 1-40 mum.
Patent IL-140839-A0 (IL)
Title: Use of tiludronic acid and derivatives thereof in poultry for the preparation of a medicinal product for preventing and treating osteoporosis
IPC: A61P19/10
Filed: 2001-01-10
Abstract: The present invention relates to the use of an active substance selected from the group consisting of tiludronic acid, one of its pharmaceutically acceptable salts, one of its hydrates and mixtures thereof, in the preparation of a medicinal product for preventing and treating osteoporosis in poultry.
Patent IL-143762-A0 (IL)
Title: An apparatus and method for determining a program neighborhood for a client node in a client-server network
IPC: H04L29/08
Filed: 1999-12-27
Abstract: An apparatus and method for determining a program neighborhood of a client node in a client-server network is described. The program neighborhood of the client node includes application programs hosted by application servers on the network. The present invention enables a user of a client node to learn of these application programs. The user is not required to know where to find such applications or to manually establish links to such applications. To make the client node aware of its program neighborhood, a host server collects application-related information corresponding to application programs hosted by the servers in the network. The application-related information can include the application name, the server location of the application, minimum capabilities required of client nodes for executing the application, and those users who are authorized to use that application. User credentials are received from the client system. The user credentials are used to filter the application-related information. Information representing those application programs that are available to the client node is transmitted from the host server to the client system for display. In a Windows-based client node, the information can be represented by a graphical icon for each available application program.
Patent IL-151167-A0 (IL)
Title: Pyrrolopyridazine derivatives and pharmaceutical compositions containing the same
IPC: C07D207/00
Filed: 2001-02-06
Abstract: A pyrrolopyridazine derivative having formula (I) or a pharmaceutically acceptable salt thereof: <CHEM>  Äwherein,   R<1> is a C2-C6 alkenyl group, a halogeno C2-C6 alkenyl group, a C3-C7 cycloalkyl group which may be optionally substituted or a C3-C7 cycloalkyl- C1-C6 alkyl group which may be optionally substituted;   R<2> is a C1-C6 alkyl group; R<3> is a hydroxymethyl group, a C2-C6 aliphatic acyloxymethyl group, a C6-C10 arylcarbonyloxymethyl group which may be optionally substituted, a C1-C6 alkoxycarbonyloxymethyl group, a formyl group, a carboxyl group, a C1-C6 alkoxycarbonyl group or a C6-C10 aryloxycarbonyl group which may be optionally substituted;   R<4> is a C6-C10 aryl group which may be optionally substituted;   A is an imino group, an oxygen atom or a sulfur atomÜ.  ÄEffectÜ   The pyrrolopyridazine derivatives of the present invention exhibit excellent gastric acid secretory inhibition activity and gastric mucous membrane protection activity etc. are useful as a medicament, preferably as a medicament for prevention or treatment of ulcerative disease.
Patent IL-153793-A0 (IL)
Title: Combined window blind and security shutter
IPC: E06B9/36
Filed: 2001-07-11
Abstract: A combined window blind and security shutter comprising; a support structure ( 51 ) securable in a window opening ( 54 ); a plurality of rigid blades ( 50 ) extending across the support structure, each blade having therein a rigid reinforcing member ( 56 ) having at each end thereof a spindle engaged in the support structure in such a manner as to maintain a parallel relationship between the blades whilst permitting rotation of the blade about the spindles; and control mechanism (e.g., such as a motorized pull cord) for simultaneously rotating the blades between a closed position, in which the blades lie substantially parallel to the window so as to form together a continuous shutter therefor, and an open position, in which the blades extend substantially normally to the window to permit light and air to pass therebetween.
Patent IL-156700-A0 (IL)
Title: Pesticidal and antiparasitic compositions
IPC: A01N63/50
Filed: 2001-12-17
Abstract: This invention relates to pesticide and antiparasitic compositions for the control of pests, diseases and parasites attacking plants and animals. The compositions include, at least one chitinolytic agent or a chitinolytic activity-inducing agent, and sulfide or a sulfide-producing agent from microorganisms or chemical compounds, wherein the chitinolytic agent or the chitinolytic activity-inducing agent and sulfur or a sulfur-producing agent obtaining from microorganisms or chemical compounds are concurrently applied at a range significantly lower than any of the above-mentioned compounds, when they are individually to attain effective control.
Patent IL-162869-A0 (IL)
Title: Use of zinc sulphite as agent for combating acarids
IPC: D01F1/10
Filed: 2003-01-13
Abstract: The invention relates to a novel use of zinc sulfide as agent for combating acarids. The invention also relates to compositions with acarid-combating properties comprising zinc sulfide as additive, in particular polymer compositions, and to yarns, fibers, filaments and articles obtained from these compositions; it is also targeted at liquid or solid compositions for cleaning and/or treating textile surfaces, in particular carpets, including fitted carpets.
Patent IL-169702-A0 (IL)
Title: Combination therapy of zd6474 with 5-fu or/and cpt-11
IPC: A61P35/00
Filed: 2005-07-17
Abstract: The present invention relates to a method for the production of an antiangiogenic and/or vascular permeability reducing effect in a warm-blooded animal such as a human, which is optionally being treated with ionising radiation, particularly a method for the treatment of a cancer, particularly a cancer involving a solid tumour, which comprises: the administration of ZD6474 in combination with 5-FU; ZD6474 in combination with CPT-11; or ZD6474 in combination with 5-FU and CPT-11.
Patent IL-194986-A0 (IL)
Title: Method and apparatus for performance and cost optimization in an internetwork
IPC: H04L12/56
Filed: 2008-10-30
Abstract: Systems and methods are described for supporting routing intelligence for evaluating routing paths based on performance measurements. The routing intelligence may include processes executed in a self-contained device. This device may control one or more edge routers, based on performance data from end users. In other embodiments, the routing intelligence device may be used solely to monitor one or more edge routers, producing reports but not effecting any changes to routing. Routing decisions may be injected to the edge routers via BGP updates. The devices may be stationed at the premises of a multihomed organization, such as an enterprise, ISP, government organization, university, or other organization supporting a sub-network coupled to an internetwork. In other embodiments, the routing intelligence comprises processes executed on a router.
Patent IL-198285-A0 (IL)
Title: Process for the measurement of the potency of glatiramer acetate
IPC: G01N33/531
Filed: 2009-04-22
Abstract: The subject invention provides a process for measuring the relative potency of a test batch of glatiramer acetate. In addition, the subject invention provides a process for preparing a batch of glatiramer acetate as acceptable for pharmaceutical use.
Patent IL-201515-A0 (IL)
Title: Selection of root indices in polyphase cazac sequences
Filed: 2009-10-14
Abstract: Systems and methods are provided to generate a set of synchronization channel sequences that optimize time and frequency acquisition. A set of root indices of Zadoff-Chu sequences in a first domain (e.g., time domain) that optimize a performance metric or merit factor are identified. An optimal index is determined that also optimizes a performance metric in a reciprocal domain (e.g., frequency domain). Optimal indices satisfy a centro-symmetric relationship with respect to a half-value of sequence length: When 1 is an optimal index, N−1 is also an optimal root index. For sequences of length Q2=N, a base sequence generated with an optimal sequence can be utilized to generate at least two disparate optimal sequences through sign-flip, conjugation, and periodic modulation operations.
Patent RO-125466-A0 (RO)
Title: Vertcial axis wind converter
Inventor: MINCIUNESCU PAUL
IPC: F03D3/00
Filed: 2009-11-06
Abstract: The invention relates to a vertical axis wind converter with high efficiency used for producing electrical energy. According to the invention, the wind converter comprises a turbine (1) driving the rotor of an electric generator by means of a vertical axis (2), a deflector (4) fixed at the converter base allowing to concentrate the air currents in the turbine (1) thereby increasing the transformation yield of the wind energy into electric energy.
Patent RO-127037-A0 (RO)
Title: System for producing electric power from wind energy, by taking over the motion of tree branches
Inventor: ANGHEL EMIL
IPC: F03D5/06
Filed: 2011-05-10
Abstract: The invention relates to a system for producing electric power from wind energy, by taking over the motion of tree branches or other objects moved by the wind. According to the invention, the system comprises a mechanical component () for taking over the wind energy, such as the branches () of a tree (), to which there is coupled, by means of some connections () and some connecting cables (), a mechanical-electrical conversion device (), which can be an electrodynamic or piezoelectric transducer that converts the mechanic strain in the connecting cables () into electric power which is further on conditioned through a conditioning system (), stored in an electric power accumulation and storing system () and finally adapted to the consumer's needs by means of an adapter-convertor (), such as an inverter-transformer assembly.
Patent RO-132417-A0 (RO)
Title: Cranial implant with osteointegration structures and functional coating
Inventor: ANTONIAC VASILE IULIAN
IPC: A61F2/28
Filed: 2017-11-09
Abstract: The invention relates to a mesh-type cranial implant made of Ti or biocompatible Ti alloys, having functional coating based on selenium and/or hydroxyapatite nanoparticles with role of osteointegration, to be used for cranioplasty and reconfiguration in big cranial defects generated by accidents, congenital anomalies, surgical extraction of tumours or other affections. According to the invention, the implant has a geometrical structure obtained based on mathematical modelling and simulation with specialized software products, and consists of a fixed layer (1) assembled with a mobile layer (2), the layers (1 and 2) being made of some osteointegration modules (3), each consisting of four basal cells (6) placed in layers, the modules (3) being connected to one another through rigid connecting bridges (4) aligned on the direction S, and through flexible connecting bridges (5) aligned on the direction S, so that the two directions intersect each other on the longitudinal axis of the implant under an angle α , the two bridges (4 and 5) together with the basal cells (6) having a porous structure and a geometry which enables the adsorption of the impregnated active substances and the proliferation of the osteoblast cells, where, for obtaining a Se nanostructured surface, the implant is immersed into a reaction medium starting from the NaHSeOprecursor and using as reducing agents various molecules from sugar category, such as starch, lactose, galactose or fructose, the ratio between NaHSeO/sugar being 1 : 4 for starch, 1 : 6 for lactose and 1 : 12 for galactose and fructose, a chemical hydro-thermal reaction takes place under magnetic stirring, resulting in a colloidal solution in which the implant is introduced for 10 min, at a temperature of 120°C, and exposed to some chemical reactions, after which the implant is extracted, washed with deionised water, subjected to a treatment with ultrasounds for 5 min and dried.